The phrase "accompanying side effects" is correct and usable in written English.
It can be used when discussing the additional effects that occur alongside a primary treatment or medication.
Example: "The medication is effective, but patients should be aware of the accompanying side effects, such as nausea and fatigue."
Alternatives: "associated side effects" or "concomitant side effects".
I remained on the drugs for a year, with all the accompanying side effects.
Although sulphonylureas, biguanides, insulin sensitizers (thiazolidinediones), and other current drugs are valuable in the treatment of type 2 diabetes mellitus, their use is restricted by cost, limited pharmacokinetic properties, secondary failure rates, and accompanying side effects [ 28].
Local delivery of reagents will be more effective at targeting with less accompanying side effects.
Inhaled delivery also potentially reduces the dose requirement and the accompanying side effects.
The majority of respondents, however, reported negative perceptions regarding the length of treatment and the accompanying side effects.
However, these inhibitors seem to inevitably accompany side effects, because Akt is also important for the survival of normal cells.
Cancer treatments often involve prolonged periods of adjuvant therapy and accompanying side-effects and thus disrupt an individual's employment, earnings and other role activities.
Chen et al performed a retrospective analysis over five decades in their institution and could impressively show that also in practice introduction of new radiotherapy treatment techniques led to reduction of accompanying side-effects [ 14, 15].
While recent years have seen various approaches to improve outcome by intensification of treatment schedules through introduction of novel induction and combination chemotherapy regimen and altered fractionation regimen, patient tolerance to higher treatment intensities is limited by accompanying side-effects.
The discovery that neuronal nAChRs are further subdivided into multiple subtypes suggests that drugs which act selectively at specific nAChR subtypes might effectively treat Parkinson's disease (PD), Alzheimer's disease (AD), schizophrenia, ADHD, depression, anxiety or pain without the accompanying adverse side effects associated with non-selective agents such as nicotine (1) and epibatidine.
Although treatment with HMBA induces remission in patients with myelodysplastic syndrome and acute myelogenoud leukemia, it is not currently used therapeutically because of the high dosage required (millimolar blood levels) and the accompanying toxic side effects (thrombocytopenia) [ 21].
